Neurology - Page 6

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Mexidol's effectiveness with carotid endarterctomy in patients with stenosis cerebral atherosclerosis

Authors:

GOLOVKIN V.I., POPOVA L.O., Svetlikov A.V., SHAPOVALOV A.S.

Place of publication:

Journal of Neurology and Psychiatry, 1, 2016

Chronic cerebrovascular failure: description of the clinical case

Authors:

VAKHNINA N.V., GROMOVA D.O., ZAKHAROV V.V., TARAPOVSKAYA A.V.

Place of publication:

Therapeutic archive 4, 2016

The systemic stressful effect of Mexidol in chronic brain ischemia

Authors:

Antipenko E.A.1*, Deryugina A.V. 2*, Gustov A.V.1*

1*GBOU VPO Nizhny Novgorod State Medical Academy of the Ministry of Health of Russia, Nizhny Novgorod;

2*National Research University "Nizhny Novgorod State University named after N.I. Lobachevsky ”, Nizhny Novgorod

Place of publication:

Journal of Neurology and Psychiatry, 4, 2016

Optimization of lipidsiting therapy in patients with ischemic stroke and type 2 diabetes mellitus

Author:
L.A. SHCHEPANKEVICH, Yu.A. NIKOLAEV, N.A. DOLGOVA

FGBNU "Research Institute of Experimental and Clinical Medicine", Novosibirsk

The effectiveness of combined therapy with Mexidol and cerebrolysine of chronic brain ischemia

Authors:
S.V. BEREZHNAYA¹, E.Z. YAKUPOV², Yu.A. ZAKHAROV³

¹State Autonomous Healthcare Institution "City Polyclinic No. 6", Kazan;
²State Budgetary Educational Institution of Higher Professional Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation, Kazan;
³State Budgetary Educational Institution of Higher Professional Education "Institute of Physics of Kazan (Volga Region) Federal University", Kazan, Russia

The value of atherosclerotic stenizing lesions of the brachiocephalous arteries in the formation of cognitive impairment

Author:

Khasanova D.R., Zhitkova Yu.V., Gasparyan A.A.

Place of publication:

NEUROLOGY. NEUROPSYCHIATRY. Psychosomatics, 2015

The results of the study of the effectiveness and safety of the use of Mexidol in patients with chronic brain ischemia

Author:
E.I. CHUKANOVA, A.S. CHUKANOVA, H.I. MAMAEVA

GBOU VPO “Russian National Research Medical University named after N.I. Pirogov ", Moscow

Oxidative stress and its correction for neurological diseases. Review of literature

Author:

A.I. Fedin

GBOU VPO “Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia

Place of publication:

Neurological practice

Issue No. 2 (5) February 2015

Aleksitimiy in patients with a heart attack of left -handed localization in the late recovery period

Authors:

Antonova N.A. , Kuznetsova E.B., Sholomov I.I.

GBOU VPO "Saratov State Medical University named after V.I. Razumovsky "of the Ministry of Health of Russia, the Department of Nervous Diseases

Place of publication:

Journal of Neurology and Psychiatry, 10, 2015

Neurometabolic therapy as a means of secondary prophylaxis of stroke

Author:
V.V. KOVALCHUK

St. Petersburg GBUZ City Hospital No. 38 named after N.A. Semashko, St. Petersburg

Oxidative stress and its drug correction by Mexidol with traumatic brain injury

Author:
N.V. GOVOROVA

State Budgetary Educational Institution of Higher Professional Education "Omsk State Medical Academy of the Ministry of Health", Omsk, Russia

The effectiveness of the drug "Mexidol" in patients with a combined traumatic brain injury

Authors:
I.B. SAVITSKAYA, V.V. NIKONOV, A.V. CHERNOV, A.Yu. PAVLENKO, A.V. BELETSKY

Kharkov Medical Academy of Postgraduate Education, Kharkov City Clinical Hospital of Emergency and Emergency Medical Assistance

Clinical experience in the use of Mexidol to correct astheno-vegetative disorders in patients who have suffered a mild traumatic brain injury

Author:
M.E. SERGIENKO

Road Clinical Hospital, Chelyabinsk

Features of the influence of Mexidol on the functional state of the central nervous system in patients who have suffered a stroke

Authors:
V.V. Kuznetsov, F.V. Yurchenko

Institute of Gerontology of AMNs of Ukraine, Kyiv

Clinical assessment of the drug Mexol in the treatment of severe traumatic brain injury at the stages of medical care

Author:
V.L. RADUSHKEVICH

Voronezh State Medical Academy. N. N. Burdenko, Voronezh

Experience with the use of Mexidol in the treatment of concussion and in the late recovery period after severe traumatic brain injury in outpatient settings

Author:
A.V. IGNATOVA

Municipal Health Institution City Polyclinic No. 26, Novosibirsk

« 1 … 4 5 6 7 »